key: cord-0711244-1plguavs
authors: Wade, Matthew J.; Jacomo, Anna Lo; Armenise, Elena; Brown, Mathew R.; Bunce, Joshua T.; Cameron, Graeme J.; Fang, Zhou; Farkas, Kata; Gilpin, Deidre F.; Graham, David W.; Grimsley, Jasmine M.S.; Hart, Alwyn; Hoffmann, Till; Jackson, Katherine J.; Jones, David L.; Lilley, Chris J.; McGrath, John W.; McKinley, Jennifer M.; McSparron, Cormac; Nejad, Behnam F.; Morvan, Mario; Quintela-Baluja, Marcos; Roberts, Adrian M.I.; Singer, Andrew C.; Souque, Célia; Speight, Vanessa L.; Sweetapple, Chris; Walker, David; Watts, Glenn; Weightman, Andrew; Kasprzyk-Hordern, Barbara
title: Understanding and managing uncertainty and variability for wastewater monitoring beyond the pandemic: Lessons learned from the United Kingdom National COVID-19 Surveillance Programmes
date: 2021-10-08
journal: J Hazard Mater
DOI: 10.1016/j.jhazmat.2021.127456
sha: b5670520af20d5141004f2028d37f2e2f83af6a1
doc_id: 711244
cord_uid: 1plguavs

The COVID-19 pandemic has put unprecedented pressure on public health resources around the world. From adversity, opportunities have arisen to measure the state and dynamics of human disease at a scale not seen before. In the United Kingdom, the evidence that wastewater could be used to monitor the SARS-CoV-2 virus prompted the development of National wastewater surveillance programmes. The scale and pace of this work has proven to be unique in monitoring of virus dynamics at a national level, demonstrating the importance of wastewater-based epidemiology (WBE) for public health protection. Beyond COVID-19, it can provide additional value for monitoring and informing on a range of biological and chemical markers of human health. A discussion of measurement uncertainty associated with surveillance of wastewater, focusing on lessons-learned from the UK programmes monitoring COVID-19 is presented, showing that sources of uncertainty impacting measurement quality and interpretation of data for public health decision-making, are varied and complex. While some factors remain poorly understood, we present approaches taken by the UK programmes to manage and mitigate the more tractable sources of uncertainty. This work provides a platform to integrate uncertainty management into WBE activities as part of global One Health initiatives beyond the pandemic.

 1 

The acquisition of data and extraction of information from environmental samples to 3 manage and improve public health has been a cornerstone of societal development for 4 nearly 200 years [1] . However, in comparison with medical and pharmaceutical innova- 5 tion, much of the work in the field of environmental public health is largely unrecognised 6 outside of the professional communities invested in its use. This is evident with wastew-7 ater, a conduit for an array of bio-and chemical markers that can be analysed to provide 8 information on human activities, behaviours, and health status in populations [2] [3] [4] [5] , 9 chain reaction (RT-qPCR) [25] , genomic sequencing [26] [27] [28] , and, more recently, mass 41 spectrometry [29] , to detect and identify the emergence and spread of novel variants in 42 the population. 43 1. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Although the COVID-19 pandemic has highlighted the benefits of ex-situ monitoring 45 human-associated disease in the environment, WBE has also been successfully applied 46 in other public health contexts, such as tracking pharmaceuticals, such as self-prescribed 47 drug usage in cities [30, 31] , antimicrobial resistance [32] , and assessment of human 48 exposure to environmental pollution [7, 10, 33] . The severity of the current pandemic 49 is a strong motivation for increased and integrated public health and environmental 50 surveillance at national and supra-national scales [34, 35] . Whether it is future-proofing 51 for potential new pandemics [36] or water fingerprinting to determine factors impacting 52 both physical and mental health in communities [37] , wastewater surveillance will become 53 a vital tool at the disposal of governments and public health authorities at the nexus of 54 public and environmental health beyond COVID-19. 55 56 The manuscript is focused on the understanding and management of uncertainty in 57 WBE, framed by, but not limited to, lessons-learned from wastewater surveillance during 58 the COVID-19 pandemic. For broader discussion of WBE and its implementation as a 59 tool for informing decision-making and policy, there are a plethora of excellent review 60 articles that may be referred to [15, 38, 39] . The data rich, technologically diverse 61 and computationally powerful resources available for WBE present an opportunity to 62 deliver next-generation public health solutions in combination with targeted or passive 63 environmental monitoring [40] . Deriving an understanding of sources of uncertainty and 64 implementing methods to estimate and account for measurement error is therefore critical 65 for the design and implementation of wastewater surveillance to support public health 66 decision-making. We posit that the insights presented here have wider consequences for 67 WBE efforts beyond the pandemic. 68 Here insights are shared from the United Kingdom (UK) WBE surveillance pro-69 grammes (See Section Appendix A for details), and the collective knowledge that has 70 4 J o u r n a l P r e -p r o o f helped support public health initiatives during the COVID-19 pandemic and beyond. The 71

proceeding sections discuss uncertainty and variability derived from source (population, 72 shedding), in-network (i.e. the pipe network acting as a wastewater collection system) 73 characteristics, and sampling and sample analysis. We conclude with four case-studies 74 related to distinct aspects of applied WBE, providing examples of how uncertainty and 75 measurement variability are addressed and managed. 76 2. Uncertainty and its impact on wastewater surveillance 77 The perceived benefits of using measurements from wastewater samples for epidemi- 78 ology include a response to the determinant of focus (e.g. disease) that captures close 79 to all of the population contributing to the signal and the provision of near real-time 80 insights obtained from changes in the magnitude or direction of this response [41] . With 81 respect to COVID-19, clinical sampling of individuals in the community, via nasopharyn-82 geal swabs, saliva or serological tests, is subject to biases associated with factors common 83

to sub-sampling of heterogeneous populations [42] , and mass-testing to obtain a repre-84 sentative sample size is costly. Wastewater, on the other hand, provides an aggregated 85 picture of community disease state through the measurement of virus RNA excreted by, 86 theoretically, all viable shedders with the disease in the sewer catchment [43] , and can 87 be implemented at a relatively low-cost in comparison with clinical sampling [44] . In 88 reality, however, the accuracy and representativeness of any measurement acquired from 89 wastewater is subject to a number of influencing factors, which can be classed as ob-90 servable (e.g. sample dilution by exogenous hydrological flows), or partially observable 91 (e.g. in-network analyte decay/degradation). Two recent reviews of wastewater-based 92

prevalence estimation [45] and, more specifically, errors associated with laboratory quan-94 tification using . 95 It is well understood that environmental measurements are subject to extraneous 96 factors that account for differing degrees of (measureable) variability and uncertainty 97

(unexplained or unmeasureable variability) in the signal (see [47] , for example), and 98

surveillance for WBE is particularly impacted by the complexity of the media being 99 sampled [37, 45, 48] . Figure 1 presents an overview of the known and potential sources of 100 5 uncertainty in WBE for COVID-19, grouped into spatiotemporal classes (i.e., where and 101 when the uncertainty is likely to impact the measurement). For COVID -19, variability 102 manifests as a significant problem when different measured virus RNA concentrations are 103 observed for, theoretically, the same proportion of infected individuals in the population. 104

More precisely, it is the uncertainty arising between the target analyte (RNA) and its 105

representation of the measure of concern, e.g. disease prevalence (number of individuals 106

with the disease at any given time) or incidence (number of newly identified individuals 107 with the disease for a particular time period). Unwanted variability can occur over time 108 at a given sample site due, for example, to rainfall or snow melt entering into a combined 109 sewer network during or after wet weather events, and diluting the analyte concentrations 110 relative to a dry weather baseline. With target analytes such as virus particles, which 111

can attach to solids in the network, the impact of increased flow in the sewer is likely 112 non-linear due to the effects of turbulence and scouring on settled solids resuspension. 113

Although, to our knowledge, no evidence of this currently exists for SARS- Variation between sites is also a problem when using WBE measurements for com-115 parison across geographies, or when aggregating to provide supra-catchment perspectives 116 of target analyte dynamics. For example, a large catchment having a long hydraulic resi-117 dence time may systematically produce lower concentration measurements than a smaller 118 site, even though the disease prevalence could be the same in both catchments. As shown 119

in Figure 1 , factors causing uncertainty or unwanted variability can range from large-120 scale processes, such as highly transient populations, to those at a smaller scale including 121 laboratory specific methods [46] . In each case, strategies are needed to account for the 122 variability in a way that is appropriate for the intended use of the data.

Uncertainty imposes a lower level of confidence on a measurement than accountable 124 and manageable (signal) variation [49] . Evaluation of uncertainty is necessary for WBE 125 as quantifying the error bounds (and understanding the limits) of sample measurements 126 is critical for capturing the inherent risk associated with public health decision-making 127 processes. These risks are similar for likely all applications of WBE, i.e. incorrect estima-128 tion of target analyte(s); inability to compare measurements from different environments 129 or under different conditions; loss of confidence in ability to detect or quantify the target 130 analyte(s). The risks associated with uncertainty to wastewater surveillance of COVID-131 6 J o u r n a l P r e -p r o o f 19 are wide-ranging and depend on its use-case. For example, recent attention focused 132 on how using measurements from wastewater in epidemiological models [50, 51] could 133 increase parametric uncertainty and error bounds on model estimates [52] . This, in turn, 134

will affect the suitability of the model for tracking and predicting the dynamics of the 135 disease [53] . Using raw wastewater measurements without accounting for factors that 136

can affect interpretation, such as wastewater dilution or signal decay, may have a sig-137 nificant impact for decision-making when used to complement other sources of disease 138 prevalence. to ensure that inter-site comparisons are made on an equivalent basis, and b) to account 145 for the effects of intra-site population change on the loads of measured target(s) in the 146 wastewater. Population size is, however, uncertain and variable. The mean population 147 7 size may be estimated based on census data and additional demographic statistics, but 148 such estimates cannot be easily updated to account for changes resulting from births, 149 deaths and migration, and can quickly become outdated [54] . Fluctuations in population 150 during the sampling period can contribute further uncertainty. These include, for exam-151 ple, weekly and seasonal variations due to the flux of commuters and tourism or student 152 populations, respectively. Dynamic population estimates may be obtained using water 153 quality parameters such as ammonia and orthophosphate; however, this is subject to bias 154 due to the contribution of additional sources such as industrial discharges [55] . The use 155 of mobile device data [56] , chemical biomarkers present in urine (e.g. caffeine, pharma-156 ceuticals) [57] or human-specific microbial/molecular markers (e.g. crAssphage, human 157 adenovirus (HAdV), JC polyomavirus (JCPyV)) [58, 59] , are alternative metrics that 158

have been shown to reduce measurement uncertainty when used to estimate population 159 size for normalisation of target analyte concentrations.

To illustrate the potential effects of population variability, Figure 2 shows the impact 161 for population normalisation as i) flow-rate data is typically not available or at a lower 171 cadence than our sampling frequency; and ii) flow rate is not proportional to population 172 due to variation in dilution.

Error bars are included in Figure 2 to indicate standard deviation (σ) resulting from 174 variability in the site-specific ammonia nitrogen discharge per capita (i.e. S d σ(x)/X d , 175 8 J o u r n a l P r e -p r o o f where σ(x) = σ(X d Q d )/P ); these do not capture any other sources of uncertainty. course implies that the concentration of SARS-CoV-2 gene copies in wastewater is a con-196 volution of disease incidence with the shedding profile [62] . Consequently, techniques for 197 relating epidemiological indicators to wastewater-based signals need to consider multiple 198 time lags, for example by employing distributed lag models [63] . Studies to investigate 199 viral shedding prior to symptom onset are urgently required because existing data have 200 been collected from hospitalised patients [64] [65] [66] . Similarly, the impact of vaccination on 201 faecal shedding of viral RNA is unknown, although data from nasal swabs suggest that 202 viral loads are likely to be reduced [67] . Given this, quantifying virus at near-source with 203 any precision remains elusive, and further work to understand faecal shedding distribu-204 tion is critical for adoption of wastewater measurements in epidemiological models for 205 estimating transmission rates (i.e. effective reproduction number, R ef f ) [68] . This infor-206 mation can be applied broadly to other analytes routinely shed in the urine and faeces 207 that correlate to public health indicators, although shedding profiles could be markedly 208 different from those for viruses. and their distribution within the sewage volumes.

The daily flow patterns in most wastewater systems are oscillatory, driven by multiple 216 factors such as sewer network design (e.g. combined or separate systems), industrial 217 discharge events and prevailing weather conditions. However, the flow signal, under dry 218 weather flow conditions, is governed by household water usage, which often presents as 219 morning and evening 'peak flow' pulses, especially in small catchments. These daily 220 oscillations are damped in catchments with a wide network or large storage capacity 221

where peak flow can be retained and processed later, leading to a homogenisation of the 222 signal [69] . Pumps across the network or at the inlet of STWs can also homogenise analyte 223 concentrations within the flow, with sumps or wet wells acting as small retention tanks. 224 10

Ingress of non-human derived flow, e.g. from rainfall or snow melt, in combined sewers, 225

or groundwater infiltration in all sewers, can bias measurements by signal dilution.

Sewer network size, sewer gradient, pipe friction, and presence of retention tanks can 227

impact the time-of-travel of wastewater 'packets' (typically < 1 to 24-hours in the UK, 228 dependent on catchment size), and may reduce target concentrations that are prone to 229 degradation [70] (i.e. those with a short T90, the time for one order of magnitude reduc-230 tion in concentration). Moreover, the type of sewage system (gravity or pressurised pipes) 231

can directly impact the decay rate of analytes of interest due to differences in biofilm 232 composition within these two environments [71] (fully anaerobic for pressurised pipes and 233 mixed anaerobic/aerobic in gravity sewers). Further, the shear stress created by cycling 234 between pressurised and unpressurised pipes might further hasten the decay of labile 235

analytes. Finally, retention tanks may also increase the binding of hydrophobic targets, 236

such as SARS-CoV-2 virions, with suspended solids to form complex matrices [72] , which 237 may obfuscate their subsequent detection by laboratory analysis, or result in settling-238 resuspension phenomena in the sewer pipes [73] , decoupling the temporal dynamics of 239 the virus RNA from the discharge event. Significant sewer pipe leakages may also in-240 fluence the fate of virus, and consequently its downstream detection and quantification, 241 especially in older networks.

Adjusting for the impact of network characteristics across a national programme is 243 challenging due to the need for quantitative, comparable information for individual site 244 networks. In England, this data is typically owned by private water utilities and, in many 245

cases, the precise configuration of the network is not known, unless access is provided 246 by the companies. However, the impact of some site characteristics can be mitigated 247 have the potential to impact the well-being of individuals and communities [69] . The 260

source of the analyte(s) targeted, through urine (e.g. metabolites of pharmaceuticals) or 261 faeces (e.g. viruses), can impose additional variability in measurements, and beyond the 262 COVID-19 pandemic, wastewater surveillance programmes will need to build in sampling 263 flexibility and rigour to account for this uncertainty [75] . As samples are not always collected daily, sampling cadence must be considered when 296 determining WBE sampling strategies. Aliasing effects may result in incorrect interpre-297 13 J o u r n a l P r e -p r o o f tation of signal dynamics, or produce artefacts in models used for back-calculation of 298 target stressors (i.e. biological, chemical and physical agents used in environmental sci-299 ence and exposure-effect analyses as determinands impacting humans and ecosystems, 300

such as SARS-CoV-2 in WBE), for example [76] . A sampling frequency as close to the 301 daily cadence will reduce uncertainty arising from temporal variability. This has been 302 quantified through a data ablation experiment for 186 network sites monitoring SARS-303

CoV-2 in England, for which a number of samples were artificially removed to compute 304 the relative bias introduced by reducing the sampling cadence, as shown in Figure when all discharge events should be captured. Technologies that can provide continuous 311 active/powered sampling, which are pumped on a timed or triggered basis, or passive 312 samplers, which collect water/solids without power and are typically lower cost, are more 313 suitable in this context [77, 78] .

Variability due to differences within and between site sampling deployment have a 315 potential to be a significant influence on the measurement, particularly when establishing 316 a national surveillance system with a large number of sites and different site personnel 317

involved. Detailed and clear sampling protocols and ongoing training of staff are essential 318 to minimise some of the sources of this variation. 

Wastewater is a highly complex and variable media, containing compounds that can 321 decrease detection sensitivity, which results in false-negative results, whilst also com-322

promising the ability to quantify the analyte of interest, such as genetic fragments, ac-323 curately. As significant knowledge performing sample analysis has been gained while 324 monitoring the COVID-19 pandemic, insights relating to the uncertainty arising from 325 SARS-CoV-2 quantification have been addressed, leading to a consolidated application 326 of wastewater lab-analysis for WBE. to pre-concentrate the virus prior to analysis. The most commonly used methods include 329 precipitation with salt or polyethene glycol (PEG [79] ), electrostatically charged mem-330 brane filtration [80] , ultrafiltration [81] , or adsorption-precipitation with aluminium chlo-331 ride or silica [82] . Due to the expense, poor availability and potential for blockages with 332 ultrafiltration devices, the English wastewater surveillance programme initially adopted 333 the PEG precipitation method. This was based on previous success at recovering viruses 334 from wastewater [83] and also that it does not require an extra step for pH measurement 335 and correction. However, the overnight precipitation step in the method increased the 336 time from sample collection to reporting. A decision was then made to switch from PEG 337 to salt (ammonium sulphate, AS) precipitation as the latter only requires a 1-hour in-338 cubation step. Parallel studies with duplicate wastewater samples showed no significant 339 differences in recovery between the two methods for SARS-CoV-2 RNA (data not shown). 340

This AS workflow now allows viral RNA to be concentrated, extracted and quantified 341 within a 24-hour window.

Another key step in SARS-CoV-2 determination from wastewater is to produce RNA 343 extracts that ensure consistency in the quantity, quality, and purity of extracted nucleic 344 acids for their applicability in downstream processes (e.g. detection, quantification, se-345 quencing). SARS-CoV-2 determination is generally carried out with a nucleic acid-based 346 PCR assay. However, given the wide-range of PCR inhibitors in wastewater and the op-347 tions available for handling them, no single method serves all applications; a multifaceted 348 approach being the best solution to avoid amplification failure. Therefore, efficient ex-349 traction methods are required to purify inhibitor-free RNA, together with the use of 350 373 With the likelihood that the use of WBE becomes a key tool for public health agencies, 374

providing data on a range of human health indicators towards One Health initiatives and 375 global health security [37, 84] , more generally, then the acuity and timeliness of the 376 generated information becomes critical to its success. The integration of both chemical-377 and biological-based WBE will be necessary to ensure that its function is both versatile 378 and resilient in the face of growing demand and extraneous factors such as climate change, 379 population movement, and infrastructure ageing, which will result in temporal and spatial 380 variation in analyte profiles [37, 85] ; not only on measured levels, but on the ability to 381 detect and measure. or communal gatherings such as sports or entertainment events), and the load placed 445 upon each STW by industrial activity. Spatial data analysis approaches can be used to 446 characterise the contribution of STW catchments to administrative geographies, which 447 enable greater integration with public health case data [86] . using recent ammonia trends is used (fitted on overall national trends over time plus 528 site specific effects). If 'capping' is an issue, where CSOs prevent sewer overloading 529 by discharging to natural water bodies, then normalising against ammonia would be 530 preferential as a more representative measure of true flow. Anecdotally, it is not thought 531 that capping is a major issue in Scottish wastewater networks, based on communication 532

with water sector professionals. 

gramme 535 The approach assumes that the flow F t at time t is not directly observable. Therefore, 536

information about the flow can be obtained by observing the correlation of concentrations 537 ρ ti of different markers i and that a dilution estimate based on a single marker is not 538 21 J o u r n a l P r e -p r o o f robust enough as it is not possible to distinguish between a decrease in flow and an 539 increase in marker load, e.g. due to a one-off industrial or agricultural discharge. The 540 model assumes

where λ 2 is the flow variance, µ i and σ 2 i are the mean and variance of the load of 542 marker i (all in log space). ⟨log F t ⟩ is fixed at 0 to identify the model.

Accounting for variable dilution using multiple markers relies on the same basic 544 premise as the approach presented for Scotland's case study, although with three key 545 differences: first, using multiple markers (such as ammonia nitrogen and orthophos-546 phate) jointly to estimate flow variability improves the accuracy of estimates. It also 547 allows us to identify outliers (such as one-off discharges), and estimate flow variability as 548 long as at least one marker is quantified (although with larger error bars). If no marker 549 is quantified, the model predicts average flows with substantial error bars. Secondly, 550 rather than assuming total marker loads are constant, they are assumed to be constant 551 in expectation. In other words, natural variability of biomarker loads is accounted for. 552 This allows to assign variable importance to different markers in a data-driven fashion. 553

For example, crAssphage gene copy concentrations exhibit more natural variability than 554 ammonia-nitrogen concentrations, and more importance should be assigned to the lat-555 ter -although both can inform our dilution estimates. Finally, a generative modelling 556 approach is used to test hypotheses in silico, and any inferences in the form of poste-557 rior distributions over parameter values include principled estimates of uncertainty. The 558 model also handles missing data gracefully and can incorporate limits of detection where 559 appropriate (not further considered here). Unfortunately, the model needs to be fit when-560 ever new data become available, and it is more computationally expensive than other 561 methods. Any combination of two or more markers can be used to estimate flows using 562 the multi-marker method provided that their total loads are constant in expectation. An 563 example of the correction for an English STW is presented in Figure 4 . 

its mitigation within the UK Wastewater Surveillance Programme 566 The analytical variability, in terms of both replicability and reproducibility, for the 567 estimation of SARS-CoV-2 in wastewater has been a major focus of the UK wastewater 568 surveillance programmes. In England, the use of two main laboratories (required due 569 to the need for high throughput analysis capacity) provided significant challenges, but 570 also opportunities to assess the reproducibility of sample analysis. Both laboratories 571 employed the AS precipitation and, despite some differences in the use of RT-qPCR 572 reagents and quantification standards, duplicate samples were analysed and found to be 573 comparable (data unpublished). In addition, an inter-laboratory ring trial was carried out 574 involving five laboratories across the four nations, three using AS precipitation and two 575 using filtration (Walker et al., 2021, unpublished 2 ). Significant differences were found 576 23 J o u r n a l P r e -p r o o f in the absolute SARS-CoV-2 concentrations measured by all laboratories. However, 577 these differences (less than one log between labs) were much lower than reported in 578 other ring trials [90] . Further, the variability between the laboratories was similar to 579 previous inter-laboratory trials for quantifying viruses (e.g. Norovirus, Hepatitis A) in 580

shellfish [91] . The differences in the SARS-CoV-2 recovery between laboratories is likely 581 due in part to the differences in the initial virus concentration method (e.g. ultrafiltration 582 versus AS precipitation) and the use of different RT-qPCR standards. The UK is now 583 contributing to discussions on the development of an ISO standard for quantifying CoV-2 in wastewater. The development of an ISO standard will enable a greater degree of 585 international collaboration and provide the basis for external proficiency testing schemes. 586

The latter will give laboratories and accreditation services a means to assess laboratory 587 performance and flag potential quality issues that require investigation.

The efficiency of downstream applications depends strongly on the purity of the RNA 589 sample used. In this regard, the Minimum Information for Publication of Quantitative 590

cleic acid quantity is essential, while an assessment of purity is desirable [92] . This is 592 particularly important to avoid false negatives when SARS-CoV-2 concentrations are 593 too low to be quantified after dilution, requiring the use of internal or external controls, 594 such as RNA/DNA spikes, to detect inhibitors and verify several other parameters of the 595 workflow (See Figure Appendix B.14) . Furthermore, the effect of wastewater properties 596 has been assessed in a range of mesocosm-based wastewater studies (Kevill et al., 2021, 597 unpublished). These found that the presence of suspended solids (turbidity range 10 -598 400 NTU) or surfactants (0 -100 mg/l) had minimal impact on RNA recovery using 599 PEG or AS precipitation methods unless present at very high concentrations atypical of 600 UK wastewater.

RT-qPCR can introduce additional variability at different steps during the quantifi-602 cation of SARS-CoV-2. Firstly, the reverse transcription can vary with the same samples 603 by two to threefold depending on the amount and quality of RNA [93] . On the other 604 hand, sample variability increases when the target complementary DNA (cDNA) is di-605 luted, mainly when the quantification cycle (C q ) values are greater than 30. This is due 606 to stochastic amplification, measurement uncertainty, and subsampling error [94] . The 607 24 J o u r n a l P r e -p r o o f RT-qPCR variability can easily range between 10% to 200% of the coefficient of variation 608 (CV) and can only be minimised by interrogating a larger proportion of the sample using 609 more technical replicates and applying the average C q [94] . Figure to understand measurement variability at an inter-city granularity (See Figure Appendix 619 B.9 for a map of the five study locations, and Table Appendix B.1 for data on their 620 network characteristics). A detailed discussion of multi-chemical fluxes in urban catch-621 ments has been provided by Proctor et al. [95] and the methodology used to measure 622 chemicals and back-calculate mass loads and intake are found in recent literature [7, 96] . The aim of the study is to understand and characterise key uncertainties to enable 641 accurate back-calculation of city-wide exposure to chemicals. To validate the devel-642 oped back-calculation protocol, high-resolution spatiotemporal National Health Service 643 (NHS) pharmaceutical prescription databases are used for system calibration, in terms 644 of biomarker selection and its correction factor, as well as for overall spatiotemporal 645 system performance evaluation. A detailed discussion on multi-chemical exposure can 646 be found in [7] . Here, focus is only given to carbamazepine and citalopram, two model 647 Prescription databases (if associated with well-defined regional units such as streets) can 674 therefore serve as internal calibration systems.

This case study shows the importance of careful biomarker selection to enable highly 676 accurate 'quantitative' calculation of per capita stressor intake. This is not currently 677 performed with SARS-CoV-2 surveillance, where the stressor itself is used as a biomarker. 678

As a result, various sources of the genetic material present in the wastewater sample can 679 be captured and, hence, calculation of the per capita intake (or viral load) may be 680 difficult. Further work is required to establish a suite of biomarkers and new analytical 681 approaches to enable quantitative measurement of community infection and public health 682 indicators of concern. In the interim, it is likely that WBE can only be used as an early 683 warning system for public health monitoring and verification of disease prevalence trends 684 at the community level, and not as a quantitative measure of community infection rates. 685 protection.

Here perspectives are provided on the confidence in wastewater-derived measurements 710 by those working across the national programmes, given work performed to understand, 711 quantify and manage measurement uncertainty and variability. The work emphasises that 712 while some sources of uncertainty may not be impactful, or can be adequately accounted 713

for (e.g. extraneous flow dilution, sampling method), other sources are inconsistent or 714 difficult to quantify directly (e.g. shedding distributions, in-network behaviour). While 715 these intractable factors will, with consolidated research efforts, become less opaque, 716

there is unlikely to be a general approach to manage measurement uncertainty for all 717 applications of WBE beyond COVID. Making use of the greatly increased capacity for 718 WBE in the UK, and more widely, will require new methods for extracting actionable 719 information from wastewater data, but also methods for determining the limits of its 720 Infrastructure, Belfast City Council and NI Water Ltd. We would also like to acknowledge 743 NI Water for providing access to use spatial data for the NI Water's Wastewater Network. 744

The following funding sources are acknowledged by the contributing authors: "National 745 week to establish a baseline before being sampled twice a week thereafter. The Wales wastewater monitoring programme started as a pilot in March 2020 as 1200 the first wave of COVID-19 spread across the UK [97] . This early work highlighted the 1201 potential for tracking SARS-CoV-2 and also led to the development of robust method-1202 ologies for extracting and quantifying the virus in wastewater [79] . This pilot phase was 1203 then expanded in September 2020 to 20 sites across the country. These sites were ini-1204 tially sampled three times per week, increasing to five weekdays by June 2021, to try and 1205 reduce the variability in the wastewater SARS-CoV-2 RNA signal and, thus, improve its 1206 usability. One of the major challenges in Wales has been the lack of on-site infrastructure 1207 needed to take composite wastewater samples. Therefore, all samples are currently taken 1208 as grab samples, targeted at the early morning wastewater peak (between 08:00 and 11:00 1209 h allowing for the wastewater surveillance of a significant portion of the NI population.

An important aspect of the approach in NI has been the use of Geographical Infor-1249 mation Systems (GIS) to develop spatial GIS-based wastewater monitoring and report- As discussed, the devolved administration programmes for COVID-19 wastewater 1273

surveillance have generated a large number of SARS-CoV-2 virus RNA measurements. 1274

As with all environmental measurements, the signal recovered will be subject to anoma-1275 lies, or outliers, that diverge from the expected data trends, with some defined statistical 1276 significance. Measurements can vary by several orders of magnitude, with extrema pos-1277 sibly representing unaccountable occurrences such as ' 'super-spreader' events, single 1278 release of highly concentrated sewage (e.g. transported from non-networked sites, in-1279 network holding tanks or wet wells), or due to sample capture of a highly aggregated, 1280 unmixed load. Alternatively, anomalies may represent measurement error or uncertainty 1281 due, for example, to inappropriate sampling frequency, miscalculation or unknown peak 1282 flow (for grab samples), or sample/laboratory contamination. Such data anomalies can 1283 cause many problems for further analysis or visualisation, and depending on context, 1284 different interventions are typically needed when they are detected.

In the English programme, post-laboratory analyses were conducted to attempt to 1286 identify measurements that may be anomalously low, by defining the likelihood that a 1287 measurement falls within some expectation criteria. In particular, a machine learning 1288 approach, using a Gradient Boosting for regression model, was trained with a quantile 1289 loss function to predict 90% SARS-CoV-2 concentration intervals at the sampled sites. 1290

These predictions were used to explore unexpectedly low data points (below the 5th 1291 percentile prediction interval) where similar sites in terms of geography and collection 1292 method exhibited relatively high measurements.

The analysis identified 762 samples as anomalous out of 25,957 that did not report a 1294 quantified value. In particular, the model highlighted low measurements during January 1295

and February 2021 despite infection rates across the country were high. The analysis 1296 could be extended to explore any recorded values that do not fall within the predicted 1297 range, whether low or high. Figure as outliers. After following this process, sites of concern are reported to the National 1314

Laboratory Service (NLS) who conducts further quality assurance. 

Under the Scottish programme, Biomathematics and Statistics Scotland (BioSS) con-1317 ducted a similar procedure, though instead the focus was on anomalously high values (e.g. 1318 spikes), with the aim of flagging and potentially removing anomalies as soon as they are 1319 recorded. A Generalised Additive Model (GAM) was used to identify when high amounts 1320 of wastewater COVID-19 (relative to case rates, or relative to the previous variability 1321 of the site) is indicative of the wastewater measure not corresponding to future cases. 1322

With a suitable threshold, this was used to remove these measurements from aggregates, 1323

and/or trigger further investigation [98] . 

The past, present, and future of public health surveillance

Evaluation of uncertainties associated with the determination of 758 community drug use through the measurement of sewage drug biomarkers

Monitoring wastewater for assessing community health: Sewage Chemical-761

Information Mining (SCIM)

Refining the uncertainties and expansion of wastewater-based epidemiology for assessing 764 population exposure to chemicals

Uncertainties associated with wastewater-based epidemiology for the estimation of

Epidemiology: Estimation of Community Consumption of Drugs and Diets

Spatiotemporal assessment of illicit drug use 781 at large scale: evidence from 7 years of international wastewater monitoring

Estimation of community-wide multi-chemical exposure via water-based chemical mining: Key 785 research gaps drawn from a comprehensive multi-biomarker multi-city dataset

Wastewater-based epidemiology: current status and future prospects

Balancing water sustainability and public health goals in the face of growing concerns 790 about antibiotic resistance

Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom 793 affected by influenza A(H1N1)pdm09

Making Water Smart

A critical review of re-798 bottlenecks

Preparedness needs research: How fundamental science 802 and international collaboration accelerated the response to COVID-19

Making waves: Collaboration in the time of SARS-CoV-2 -rapid development of an 813 international co-operation and wastewater surveillance database to support public health decision-814

Wastewater-Based Epi-823 demiology: Global collaborative to maximize contributions in the fight against COVID-19

Show us 827 the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps, medRxiv

Wastewater COVID-19 the UK: summary for SAGE

What do we know?

Potential 837 discharge, attenuation and exposure risk of SARS-CoV-2 in natural water bodies receiving treated 838

Occurrence, fate and removal of SARS-CoV-2 in wastewater: Current knowl-840

edge and future perspectives

SARS-CoV-2 coronavirus in water and wastewater: A critical review about presence 844 and concern

Persistence of SARS-CoV-2 in water and wastewater

Investigation of SARS-CoV-2 faecal shedding in the community: a 850 prospective household cohort study (COVID-LIV) in the UK

Prevalence and persistent shedding of fecal

SARS-CoV-2 RNA in patients with COVID-19 infection: A systematic review and meta-analysis

ologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives

Wastewater Monitoring of SARS-CoV-2 Variants

Demonstration Case Study for Bristol

Group for Emergencies

Genome sequencing of sewage detects regionally prevalent 867

SARS-CoV-2 variants

Detection of genomic variants 871

SARS-CoV-2 circulating in wastewater by high-throughput sequencing, medRxiv

CoV-2 proteins in wastewater samples by mass spectrometry

pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure 880 and consumption data for 8 European cities

Estimating community drug 883 abuse by wastewater analysis

Sewage Surveillance project consortium

Challenges in Measuring the Recovery of SARS-950

CoV-2 from Wastewater

Distinguishing variability from uncertainty

Wastewater-Based Epidemiology for Managing 955

the COVID-19 Pandemic

COVID-19 Wastewater Epidemiology: A Model to Estimate Infected 959

The impact of uncertainty on predictions of the CovidSim 962 epidemiological code

Abu 965

outbreak monitoring using wastewater-based epidemiology in Qatar

Real-time estimation of small-area populations with human biomarkers in sewage

ammonium in wastewater-based epidemiology: application to illicit drug monitoring

Use of mobile device data to better estimate 974 dynamic population size for wastewater-based epidemiology

Estimating population size in wastewater-based epidemiology

Valencia metropolitan area as a case study

Monitoring waves of the COVID-19 pandemic: Inferences from WWTPs of 981 different sizes

crAssphage as a human molecular marker 984 to evaluate temporal and spatial variability in faecal contamination of urban marine bathing water

Inferring SARS-CoV-2 rna shedding 987 to time of infection

ceutical drug consumption estimated via wastewater analysis. Part B: Placing back-calculations in 990

Sars-cov-2 titers in wastewater are higher than expected from clinically confirmed cases

Measurement of SARS-CoV

RNA in wastewater tracks community infection dynamics

Shedding of SARS-CoV-2 in feces and 1003

urine and its potential role in person-to-person transmission and the environment-based spread of 1004

Aligning SARS-CoV-2 indicators via an epidemic 1006 model: application to hospital admissions and rna detection in sewage sludge, Health Care Manag

Duration of SARS-CoV-2 viral shedding in faeces as a parameter 1009 for wastewater-based epidemiology: Re-analysis of patient data using a shedding dynamics model

Prevention 1018 and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines

Wastewater-based estimation of the effective reproductive number of 1023 SARS-CoV-2, medRxiv

Sampling for pharmaceuticals and personal care prod-1025

ucts (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review

Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA

wastewater to inform application in wastewater-based epidemiolog

Potential impact of the sewer system on 1033 the applicability of alcohol and tobacco biomarkers in wastewater-based epidemiology

The fate of SARS-COV-2 in WWTPs points out the sludge line as a suitable spot for detection of 1037

Modelling the sewer-treatment-urban river system in view of the EU Water Framework 1039

Co-quantification of crassphage increases confidence in wastewater-based epidemiology 1042 for SARS-CoV-2 in low prevalence areas

The characterization of feces and urine: A review of 1045 the literature to inform advanced treatment technology

Sampling frequency for water quality variables in streams: Systems 1048 analysis to quantify minimum monitoring rates

Passive sampling of wastewater as a tool for the 1051 long-term monitoring of community exposure: Illicit and prescription drug trends as a proof of 1052 concept

Sampling trace organic compounds in water: 1054 a comparison of a continuous active sampler to continuous passive and discrete sampling methods

Concentration and Quantification of SARS-CoV-2 RNA in Wastewater Using Polyethylene Glycol-1058

Based Concentration and qRT-PCR

Comparison of virus concentration methods for the RT-qPCR-based recovery of 1062

murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater

Monitoring SARS-CoV-2 1066 circulation and diversity through community wastewater sequencing, the Netherlands and Belgium

SARS-CoV-2 1069 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

Seasonal and spatial 1072 dynamics of enteric viruses in wastewater and in riverine and estuarine receiving waters

Wastewater-based epidemiology booming with new funding, cdc program

Costs, climate and contamination: Three 1079 drivers for citywide sanitation investment decisions

Association between community-based self-reported COVID-19

toms and social deprivation explored using symptom tracker apps: a repeated cross-sectional study 1084 in Northern Ireland

Quantitative analysis of SARS-CoV-2 RNA from wastewater solids communities with 1088 low COVID-19 incidence and prevalence

RNA in wastewater settled solids is associated with COVID-19 cases in a large urban sewershed

Randomized stratified sampling methodology for wa-1095 ter quality in distribution systems

CoV-2 Interlaboratory Consortium, Reproducibility and sensitivity of 36 methods to quantify the 1100

SARS-CoV-2 genetic signal in raw wastewater: findings from an interlaboratory methods evaluation 1101 in the u.s

Validation of EN ISO method 15216 -Part 1 Quantification of hepatitis A 1104 and norovirus in food matrices

The MIQE guidelines: minimum information 1108 for publication of quantitative real-time PCR experiments

Variability of 1111 the reverse transcription step: practical implications

The ultimate qPCR ex-1114 periment: producing publication quality, reproducible data the first time

Micropollutant fluxes in urban environment -A catchment perspective

Multi-residue ultra-performance 1120 liquid chromatography coupled with tandem mass spectrometry method for comprehensive multi-1121

class anthropogenic compounds of emerging concern analysis in a catchment-based exposure-driven 1122 study

Monitoring SARS-CoV-2 in municipal wastewater 1125 to evaluate the success of lockdown measures for controlling COVID-19 in the UK

How outliers are identified in the wastewater data, in: Coronavirus (COVID-19): mod-1128 elling the epidemic

Bunce: Supervision, Writing -Review & editing Graeme J. Cameron: Resources, Writing -review & editing Zhou Fang: Formal analysis, Investigation, Methodology, Writing -Original draft preparation Kata Farkas: Investigation, Methodology, Resources, Writing -Original draft preparation Deidre F. Gilpin: Writing -Review & editing David W. Graham: Funding acquisition, Resources, Supervision, Writing -review & editing Jasmine M.S. Grimsley: Supervision, Conceptualisation, Methodology, Writing -Review & editing Alwyn Hart: Methodology, Resources, Writing -Original draft preparation Till Hoffmann: Formal analysis, Investigation, Methodology, Writing -Original draft preparation Katherine J. Jackson: Resources, Writing -Review & editing David L. Jones: Funding acquisition, Methodology, Resources, Supervision, Writing -Original draft preparation

Formal analysis, Methodology, Writing -Original draft preparation

Funding acquisition, Supervision, Writing -Original draft preparation Célia Souque: Formal analysis, Investigation, Methodology Vanessa L. Speight: Funding acquisition, Writing -Original draft preparation Chris Sweetapple: Formal analysis, Investigation, Methodology, Writing-Original draft preparation David Walker: Resources, Writing -Review & editing Glenn Watts: Resources, Supervision, Writing -Review & editing, Andrew Weightman: Resources, Writing -Review & editing Barbara Kasprzyk-Hordern: Conceptualisation, Formal analysis, Funding acquisition

Wastewater monitoring of COVID-19 across the four nations of the United Kingdom is 1133 the most striking example of an application of WBE for public health surveillance to date, 1134given the scale and extent of the sampling programmes, and end-to-end transformation 1135 of measurements to actionable insights. Here, a description of each national programme 1136 is provided to provide context for understanding the challenges around measurement 1137 uncertainty and variability. 

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f Highlights  Wastewater is a relatively unbiased medium transporting multiple markers of human health  Biological-and chemical-based Wastewater-Based Epidemiology will provide greater flexibility and resilience for public health security  Measurements of target analytes in wastewater are subject to variability and uncertainty  Identifying and mitigating uncertainty requires multi-disciplinary collaboration  UK wastewater monitoring programmes have generated a substantial data resource to derive better understanding of uncertainty